EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 6,570.00
-10.00 (-0.15%)
Jun 10, 2026, 3:30 PM KST
EASY BIO,Inc. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 490,700 | 476,939 | 384,331 | 165,385 | 155,557 | 129,458 | |
Revenue Growth (YoY) | 11.05% | 24.10% | 132.38% | 6.32% | 20.16% | - |
Cost of Revenue | 362,083 | 356,446 | 286,243 | 113,682 | 108,612 | 89,388 |
Gross Profit | 128,617 | 120,493 | 98,088 | 51,703 | 46,945 | 40,070 |
Selling, General & Admin | 69,850 | 66,291 | 56,931 | 27,710 | 26,952 | 20,575 |
Research & Development | 3,416 | 3,118 | 3,034 | 2,487 | 2,426 | 1,744 |
Amortization of Goodwill & Intangibles | 2,728 | 2,707 | 2,287 | 438.05 | 323.7 | 112.06 |
Other Operating Expenses | 2,439 | 2,283 | 2,140 | 268.54 | 217.04 | 167.89 |
Operating Expenses | 79,515 | 75,504 | 65,697 | 31,072 | 30,790 | 23,291 |
Operating Income | 49,102 | 44,990 | 32,391 | 20,631 | 16,155 | 16,779 |
Interest Expense | -6,640 | -7,535 | -9,025 | -3,219 | -1,720 | -1,105 |
Interest & Investment Income | 2,068 | 2,475 | 3,299 | 1,333 | 534.54 | 347.87 |
Currency Exchange Gain (Loss) | 1,774 | -1,158 | 2,558 | 981.1 | -1,670 | -160.27 |
Other Non Operating Income (Expenses) | -957.35 | -926.25 | -1,529 | -1,878 | -1,907 | -1,821 |
EBT Excluding Unusual Items | 45,346 | 37,845 | 27,696 | 17,848 | 11,392 | 14,041 |
Gain (Loss) on Sale of Investments | 1,074 | 807.24 | 1,035 | 2,224 | 592.15 | 12.04 |
Gain (Loss) on Sale of Assets | -58.99 | 4.76 | -114.65 | -7.04 | -0.33 | 0.9 |
Asset Writedown | - | - | -2,241 | - | - | - |
Pretax Income | 46,362 | 38,657 | 26,376 | 20,066 | 11,984 | 14,054 |
Income Tax Expense | 11,190 | 9,385 | 6,472 | 3,965 | 2,637 | 3,212 |
Earnings From Continuing Operations | 35,172 | 29,272 | 19,904 | 16,101 | 9,347 | 10,842 |
Minority Interest in Earnings | -1,758 | -1,494 | -299.18 | -557.26 | -216.61 | 30.73 |
Net Income | 33,415 | 27,778 | 19,604 | 15,544 | 9,131 | 10,873 |
Net Income to Common | 33,415 | 27,778 | 19,604 | 15,544 | 9,131 | 10,873 |
Net Income Growth | 63.20% | 41.69% | 26.12% | 70.24% | -16.02% | - |
Shares Outstanding (Basic) | 33 | 33 | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 33 | 33 | 34 | 34 | 34 | 34 |
Shares Change (YoY) | -1.44% | -2.28% | -0.83% | - | - | - |
EPS (Basic) | 1009.60 | 839.66 | 579.08 | 455.33 | 267.47 | 318.50 |
EPS (Diluted) | 1009.60 | 839.66 | 579.00 | 455.00 | 267.00 | 318.50 |
EPS Growth | 65.61% | 45.02% | 27.25% | 70.41% | -16.17% | - |
Free Cash Flow | 27,494 | 28,782 | 21,510 | 31,798 | -10,079 | 12,231 |
Free Cash Flow Per Share | 830.72 | 870.02 | 635.37 | 931.49 | -295.24 | 358.30 |
Dividend Per Share | 250.000 | 250.000 | 200.000 | 100.000 | 75.000 | 75.000 |
Dividend Growth | 25.00% | 25.00% | 100.00% | 33.33% | - | - |
Gross Margin | 26.21% | 25.26% | 25.52% | 31.26% | 30.18% | 30.95% |
Operating Margin | 10.01% | 9.43% | 8.43% | 12.47% | 10.38% | 12.96% |
Profit Margin | 6.81% | 5.82% | 5.10% | 9.40% | 5.87% | 8.40% |
Free Cash Flow Margin | 5.60% | 6.04% | 5.60% | 19.23% | -6.48% | 9.45% |
EBITDA | 57,462 | 53,319 | 39,896 | 24,323 | 19,918 | 19,580 |
EBITDA Margin | 11.71% | 11.18% | 10.38% | 14.71% | 12.80% | 15.13% |
D&A For EBITDA | 8,360 | 8,329 | 7,505 | 3,692 | 3,763 | 2,801 |
EBIT | 49,102 | 44,990 | 32,391 | 20,631 | 16,155 | 16,779 |
EBIT Margin | 10.01% | 9.43% | 8.43% | 12.47% | 10.38% | 12.96% |
Effective Tax Rate | 24.14% | 24.28% | 24.54% | 19.76% | 22.00% | 22.86% |
Advertising Expenses | - | 1,098 | 873.74 | 830.48 | 690.36 | 342.02 |